Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease

J Clin Oncol. 1994 Aug;12(8):1739-40. doi: 10.1200/JCO.1994.12.8.1739.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Hodgkin Disease / pathology*
  • Hodgkin Disease / radiotherapy
  • Humans
  • Mediastinal Neoplasms / pathology*
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Randomized Controlled Trials as Topic